COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials

Children usually present with milder symptoms of COVID-19 as compared with adults. Supportive care alone is appropriate for most children with COVID-19. Antiviral therapy may be required for those with severe or critical diseases. Currently there has been a rapid development of vaccines globally to...

Descripción completa

Detalles Bibliográficos
Autores principales: Galindo, Ramon, Chow, Heather, Rongkavilit, Chokechai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130516/
https://www.ncbi.nlm.nih.gov/pubmed/34538306
http://dx.doi.org/10.1016/j.pcl.2021.05.004
Descripción
Sumario:Children usually present with milder symptoms of COVID-19 as compared with adults. Supportive care alone is appropriate for most children with COVID-19. Antiviral therapy may be required for those with severe or critical diseases. Currently there has been a rapid development of vaccines globally to prevent COVID-19 and several vaccines are being evaluated in children and adolescents. Currently, only the Pfizer–BioNTech messenger RNA vaccine is approved for emergency authorization use in the pediatric population ages 16 years and older.

Ejemplares similares